SYBLEU INC (SYBE)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 477.5 Thousand USD | 241.07% |
| 2021 | 140 Thousand USD | 1469.68% |
| 2020 | 8919.00 USD | -21.27% |
| 2019 | 11.32 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q3 | 483 Thousand USD | 1.15% |
| 2023 Q2 | 477.5 Thousand USD | 241.07% |
| 2023 Q1 | 140 Thousand USD | 0.0% |
| 2023 Q4 | 488.5 Thousand USD | 1.14% |
| 2022 Q4 | 140 Thousand USD | 0.0% |
| 2022 Q3 | 140 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 98.841% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | 88.416% |
| SQZ Biotechnologies Company | 27.47 Million USD | 98.262% |
| Evofem Biosciences, Inc. | 43.37 Million USD | 98.899% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 98.396% |
| Mesoblast Limited | 118.7 Million USD | 99.598% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | 49.645% |
| Genus plc | 233.1 Million USD | 99.795% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | 83.705% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | 64.461% |
| Marizyme, Inc. | 18.71 Million USD | 97.449% |
| ContraFect Corporation | 2.88 Million USD | 83.426% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | 36.333% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -252.432% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | 66.985% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | 79.471% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | 91.561% |
| MultiCell Technologies, Inc. | 202.58 USD | -235609.349% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 99.169% |
| EV Biologics, Inc. | 1.49 Million USD | 68.055% |
| Q BioMed Inc. | 4.1 Million USD | 88.382% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 98.557% |
| Neon Bloom, Inc. | 630.07 Thousand USD | 24.216% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | 61.127% |
| Biomind Labs Inc. | 735.54 Thousand USD | 35.082% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | 99.722% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | 96.326% |
| Skye Bioscience, Inc. | 4.61 Million USD | 89.654% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | 46.231% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -237.413% |
| Arch Therapeutics, Inc. | 5.87 Million USD | 91.867% |
| IMV Inc. | 28.88 Million USD | 98.347% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -1756.604% |
| Curative Biotechnology, Inc. | 2.25 Million USD | 78.857% |
| GB Sciences, Inc. | 1.75 Million USD | 72.859% |
| Alpha Cognition Inc. | 1.22 Million USD | 60.873% |
| HST Global, Inc. | 98.31 Thousand USD | -385.664% |
| CSL Limited | 12.18 Billion USD | 99.996% |
| Halberd Corporation | 150 Thousand USD | -218.333% |
| Enzolytics Inc. | 996.33 Thousand USD | 52.074% |
| Resverlogix Corp. | 6.49 Million USD | 92.644% |
| Affymax, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -86.821% |
| argenx SE | 20 Million USD | 97.613% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 98.952% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 82.372% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -4569.927% |
| Genscript Biotech Corporation | 417.73 Million USD | 99.886% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -138.017% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | 80.085% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -108.251% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 99.294% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | 84.221% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -32.746% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | 97.651% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -221.216% |
| BioStem Technologies, Inc. | 4.71 Million USD | 89.865% |
| ONE Bio Corp. | 19.71 Million USD | 97.578% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -90.861% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -91.983% |
| Agentix Corp. | 50 Thousand USD | -855.0% |
| LadRx Corporation | 33.6 Thousand USD | -1320.877% |
| Cell Source, Inc. | 9.25 Million USD | 94.84% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | 36.856% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | 36.856% |
| NovAccess Global Inc. | 2.19 Million USD | 78.294% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 93.249% |
| Itoco Inc. | 228.37 Thousand USD | -109.084% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -126.33% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | 90.417% |
| Kadimastem Ltd | 891.22 Thousand USD | 46.422% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -18.826% |
| CytoDyn Inc. | 30.07 Million USD | 98.412% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | 1.401% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -35.712% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | 93.894% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -289.796% |
| Rebus Holdings, Inc. | 310 Thousand USD | -54.032% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | 89.916% |
| International Stem Cell Corporation | 4.17 Million USD | 88.571% |
| Bioxytran, Inc. | 1.92 Million USD | 75.195% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -665.065% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 78.105% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | 94.258% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | 94.438% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | 69.302% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -78.172% |
| Neutra Corp. | 54.15 Thousand USD | -781.712% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | 73.907% |
| PureTech Health plc | 25.51 Million USD | 98.128% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | 60.996% |
| IXICO plc | 472.02 Thousand USD | -1.16% |
| IntelGenx Technologies Corp. | 15.5 Million USD | 96.92% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 99.233% |
| CSL Limited | 12.18 Billion USD | 99.996% |
| Cellectis S.A. | 92.77 Million USD | 99.485% |